Skip to main content
. Author manuscript; available in PMC: 2021 Mar 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2020 Oct 23;86(6):815–827. doi: 10.1007/s00280-020-04176-z

Table 1.

Patient demographics

Patient demographics
Patients enrolled (treated) 29a (28)
Male/female 8/21
Median age in years (range) 60 (34–76)
Median number of prior therapies (range) 6 (2–12)
Diagnoses
 Ovarian (incl. high-grade serous ovarian cancer, Sertoli-Leydig tumor, and granulosa cell tumor) 11
Endometrial (incl. carcinosarcoma) 4
Colorectal cancer 4
Non-small cell lung cancer 3
Sarcoma (incl. gastrointestinal stromal tumor and myxofibrosarcoma) 2
Oropharyngeal (incl. salivary gland cancer and palate adenocarcinoma) 2
Cervical cancer 1
Breast cancer 1
a

One patient with squamous cell carcinoma of head and neck was enrolled but never received treatment